{
  "development": {
    "text": "Springer Nature is opening its resources related to the Zika virus, including articles, commentaries, blog posts and news items. Experts, selected primarily from our pool of authors, have written overviews that provide useful information to students, researchers, health care professionals and other scientifically minded individuals. Coming from a broad spectrum of disciplines, these experts write about how their particular field is involved in the scientific investigations to contain the virus and care for patients. Each overview offers a selection of freely available content as chosen by the author.  Further content will be posted as it becomes available.   On 10 February 2016, a group of leading global health bodies including academic journals, NGOs, research funders and institutes published a joint statement committing to share data and results relevant to the current Zika crisis and future public health emergencies.  This is in line with a consensus statement agreed at a WHO expert consultation in 2015 on data sharing.   — Bill Gates Bill Gates  We are committed to putting these pledges into action, therefore Springer Nature is opening its resources related to the Zika virus, including articles, commentaries, blog posts and news items.  Ho Chi Minh City  Recently I attended the ECB17 in Krakow, Poland.  Sessions covered the colors of biotech and presented front-line science that will form the basis for future commercial innovation. It’s no surprise that one of the opening plenaries centered on Genome engineering with CRISPR-Cas9, a topic that’s been dominating the Most Read / Most Downloaded lists of top biotech journals, e.g. articles focused on CRISPR-Cas9 currently make up almost half of Nature Biotechnology’s Top 10 most read articles.   Recently I attended the ECB17 in Krakow, Poland.  Sessions covered the colors of biotech and presented front-line science that will form the basis for future commercial innovation. It’s no surprise that one of the opening plenaries centered on Genome engineering with CRISPR-Cas9, a topic that’s been dominating the Most Read / Most Downloaded lists of top biotech journals, e.g. articles focused on CRISPR-Cas9 currently make up almost half of Nature Biotechnology’s Top 10 most read articles.   SpringerLink: Usuário administrador        © copyright information  By doing this, Springer Nature is offering the general public a platform for learning about new scientific developments concerning this epidemic. The selected content is drawn from Nature, Springer, BioMed Central, Palgrave Macmillan journals, the AdisInsight database as well as Scientific American.  H1: Text H2: Text H3: Text H4: Text Read the expert commentaries.  abc   © copyright information  def Further content will be posted as it becomes available.  Layout Table Column 1 Column 2 with a longer title Column 3 Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et	but not so much text	Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et Another row of text	Another row of text	Another row of text Downloads",
    "confidence": "0.35",
    "doi": "10.1007%2Fs00268-017-4218-x"
  }
}